https://pubmed.ncbi.nlm.nih.gov/37877759/
Although there are no pathognomonic features, histologic evaluation of suspected DILI during MASH clinical trials may alter patient management, define the...
liver biopsyassessmentsuspecteddruginduced
https://www.wolterskluwer.com/fr-be/solutions/ovid/biopsy-interpretation-of-the-liver-5839
Part of the highly regarded Biopsy Interpretation Series , this book provides practical, highly illustrated information on the diagnosis and prognosis of the...
wolters kluwerovidbiopsyinterpretationliver
https://pubmed.ncbi.nlm.nih.gov/34118335/?dopt=Abstract
Alcohol is the leading cause of death and illness due to liver disease. In this study, we assessed the ability of biomarkers to predict the risk of developing...
liver biopsyprognosticperformancebiomarkerscompared
https://alpha1.org/dr-virginia-clark-findings-from-comparison-of-vcte-fibroscan-to-liver-biopsy/
Dec 10, 2025 - Dr. Virginia Clark reviews a 3-year study comparing VCTE FibroScan to liver biopsy for staging F2/F3 fibrosis in AATD liver disease patients.
virginia clarkdrfindingscomparisonfibroscan